Brand Name | Mutaflor |
Generic Name | E. coli Nissle 1917 |
Drug Class | Probiotic |
Availability | OTC/Supplement |
Manufacturer | Ardeypharm |
Indications | Ulcerative Colitis, Crohn's Disease |
Type | Capsule, Oral Suspension |
Doses | 200 mg daily (1 capsule per day). |
Route | Oral (Capsule) |
Side Effects | Bloating, flatulence, abdominal discomfort |
Interactions | Generally safe; rare interactions; avoid during acute illness |
Overdose | Generally safe; possible flatulence. |
Missed Dose | Take as convenient. |
Contraindications | Immunocompromised individuals, critically ill (caution). |
Alternatives | Other probiotics |
Co-Pay Assistance Program | Investigational |
Patient Assistance Program | Not available |
E. coli Nissle 1917 is a probiotic used to treat gastrointestinal disorders, particularly inflammatory bowel diseases such as ulcerative colitis.
This probiotic strain works by promoting gut health, maintaining the balance of gut microbiota, and reducing inflammation in the intestines.
E. coli Nissle 1917 is generally safe with few side effects, but in rare cases, it can cause bloating or digestive discomfort.
E. coli Nissle 1917 is typically taken orally in capsule or liquid form. The dosage will depend on your healthcare provider's recommendations.
E. coli Nissle 1917 is generally considered safe during pregnancy, but it's important to consult your healthcare provider before starting any new supplements.
Yes, E. coli Nissle 1917 can help with symptoms of irritable bowel syndrome (IBS) by improving gut microbiota balance and reducing inflammation.
If you miss a dose, take it as soon as you remember unless it's close to your next dose. Do not take two doses at once.
Generally, E. coli Nissle 1917 does not interact with medications, but it is always a good idea to inform your doctor about all supplements you are taking.
It may take several weeks for E. coli Nissle 1917 to show noticeable improvements in gut health and symptoms of gastrointestinal conditions.
Yes, E. coli Nissle 1917 has been shown to be effective in maintaining remission in patients with mild to moderate ulcerative colitis.
Related Conditions |
Related Blogs |
---|---|